Hospital-acquired infection test kit ELITe MGB® RTS200ING
enterobacteriaceaefor real-time PCR

hospital-acquired infection test kit
hospital-acquired infection test kit
Add to favorites
Compare this product


for hospital-acquired infections
Analysis mode
for real-time PCR


Carbapenem-Resistant Enterobacteriaceae (CRE) are bacteria resistant to carbapenems, the antibiotics of “last resort”. CRE are responsible for serious infections much more difficult to treat with higher morbidity and mortality in hospitals. Rapid and reliable Carbapenem-Resistant Enterobacteriaceae detection with molecular methods is crucial to identify infected patients, implement infection measure controls, and avoid outbreak in hospital and healthcare settings. CRE ELITe MGB® Kit is a multiplex real-time PCR assay designed for the detection and the differentiation of all main relevant classes of Carbapenem-Resistant Enterobacteriaceae genes: KPC (serine carbapenemases genes), NDM, VIM, IMP (metallo beta-lactamases genes), and OXA-48 like (OXA carbapenemases genes). The assay is CE-IVD validated on different samples types, in combination with ELITe InGenius®, a fully automated sample-to-result solution.


No catalogs are available for this product.

See all of ELITech Group ‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.